Mark D. Prairie
Impact in
- Toxicology top 2%
- Bioactive Compounds and Antitumor Agents
- Organic Chemistry top 10%
- Synthesis and Biological Evaluation
Papers in
-
- Cancer therapeutics and mechanisms 10
- DNA and Nucleic Acid Chemistry 8
- Chemical Synthesis and Analysis 3
- DNA Repair Mechanisms 2
- Biopolymer Synthesis and Applications 2
- Advanced biosensing and bioanalysis techniques 2
- Co-authors
- William C. Krueger (18 shared papers)Robert C. Kelly (4 shared papers)J. Patrick McGovren (2 shared papers)Tanya L. Wallace (3 shared papers)Gary L. Petzold (4 shared papers)Martha A. Warpehoski (2 shared papers)Nancy A. Wicnienski (2 shared papers)Wendell Wierenga (1 shared paper)
- Journals
- Chemico-Biological Interactions (7 papers)Journal of Medicinal Chemistry (3 papers)Biopolymers (2 papers)Cancer Letters (1 paper)Investigational New Drugs (1 paper)
- Partner nations
- United StatesNorway
In The Last Decade
Mark D. Prairie
21 papers receiving 421 citations
Peers
Comparison fields: 5 of 52
- Toxicology 70
- Organic Chemistry 160
- Molecular Biology 354
- Pharmacology 55
- Cancer Research 44
Countries citing papers authored by Mark D. Prairie
This map shows the geographic impact of Mark D. Prairie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. Prairie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. Prairie more than expected).
Fields of papers citing papers by Mark D. Prairie
This network shows the impact of papers produced by Mark D. Prairie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. Prairie. The network helps show where Mark D. Prairie may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark D. Prairie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1988 | 117 | |
| 2 | Cytotoxicity and antitumor activity of carzelesin, a prodrug cyclopropylpyrroloindole analogue. | 1992 | 81 |
| 3 | 1984 | 47 | |
| 4 | 1985 | 30 | |
| 5 | 1987 | 27 | |
| 6 | 1990 | 21 | |
| 7 | 1985 | 18 | |
| 8 | 1986 | 17 | |
| 9 | 1987 | 11 | |
| 10 | 1991 | 8 | |
| 11 | 1995 | 7 | |
| 12 | 1992 | 7 | |
| 13 | 1988 | 7 | |
| 14 | 1988 | 7 | |
| 15 | 1992 | 6 | |
| 16 | 1999 | 6 | |
| 17 | 1991 | 6 | |
| 18 | 1992 | 5 | |
| 19 | 1988 | 5 | |
| 20 | Interaction of CC-1065 and its analogues with mouse DNA and chromatin. | 1989 | 4 |
About Mark D. Prairie
Mark D. Prairie is a scholar working on Molecular Biology, Organic Chemistry, Toxicology, Pharmacology and Pharmaceutical Science, having authored 21 papers that have together received 438 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (10 papers), DNA and Nucleic Acid Chemistry (8 papers), Bioactive Compounds and Antitumor Agents (4 papers), Chemical Synthesis and Analysis (3 papers), DNA Repair Mechanisms (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Biopolymer Synthesis and Applications (2 papers) and Advanced biosensing and bioanalysis techniques (2 papers). The work is most often cited by research in Toxicology (70 citations), Organic Chemistry (160 citations), Molecular Biology (354 citations), Pharmacology (55 citations) and Cancer Research (44 citations). Mark D. Prairie has collaborated with scholars based in United States and Norway. Frequent co-authors include William C. Krueger, Robert C. Kelly, J. Patrick McGovren, Tanya L. Wallace, Gary L. Petzold, Martha A. Warpehoski, Nancy A. Wicnienski, Wendell Wierenga, Ilse Gebhard and T F Dekoning. Their work appears in journals such as Chemico-Biological Interactions, Journal of Medicinal Chemistry, Biopolymers, Cancer Letters and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.